PL374954A1 - Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction - Google Patents

Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction

Info

Publication number
PL374954A1
PL374954A1 PL374954A PL37495405A PL374954A1 PL 374954 A1 PL374954 A1 PL 374954A1 PL 374954 A PL374954 A PL 374954A PL 37495405 A PL37495405 A PL 37495405A PL 374954 A1 PL374954 A1 PL 374954A1
Authority
PL
Poland
Prior art keywords
antagonists
oxitocin
oxytocin
vasopressin
aided
Prior art date
Application number
PL374954A
Other languages
Polish (pl)
Inventor
Waldemar Kuczyński
Piotr Pierzyński
Original Assignee
Waldemar Kuczyński
Piotr Pierzyński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waldemar Kuczyński, Piotr Pierzyński filed Critical Waldemar Kuczyński
Priority to PL374954A priority Critical patent/PL374954A1/en
Priority to DE602006021736T priority patent/DE602006021736D1/en
Priority to ES06747719T priority patent/ES2366130T3/en
Priority to CA2605923A priority patent/CA2605923C/en
Priority to RU2007140702/15A priority patent/RU2385735C2/en
Priority to PL06747719T priority patent/PL1879572T3/en
Priority to CN2006800568367A priority patent/CN101646436B/en
Priority to EP06747719A priority patent/EP1879572B1/en
Priority to MX2007014022A priority patent/MX2007014022A/en
Priority to NZ562409A priority patent/NZ562409A/en
Priority to PT06747719T priority patent/PT1879572E/en
Priority to PCT/PL2006/000029 priority patent/WO2006121362A2/en
Priority to KR1020077025706A priority patent/KR100985449B1/en
Priority to AT06747719T priority patent/ATE507830T1/en
Priority to JP2008511075A priority patent/JP4762308B2/en
Priority to DK06747719.0T priority patent/DK1879572T3/en
Priority to AU2006244693A priority patent/AU2006244693B2/en
Priority to SI200631039T priority patent/SI1879572T1/en
Priority to US11/914,049 priority patent/US20080318847A1/en
Publication of PL374954A1 publication Critical patent/PL374954A1/en
Priority to IL186595A priority patent/IL186595A/en
Priority to NO20076328A priority patent/NO340956B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PL374954A 2005-05-10 2005-05-10 Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction PL374954A1 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
PL374954A PL374954A1 (en) 2005-05-10 2005-05-10 Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction
NZ562409A NZ562409A (en) 2005-05-10 2006-05-10 Use of barusiban in assisted reproduction
KR1020077025706A KR100985449B1 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
CA2605923A CA2605923C (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin
RU2007140702/15A RU2385735C2 (en) 2005-05-10 2006-05-10 Application of oxytocin antagonists in assisted reproduction
PL06747719T PL1879572T3 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
CN2006800568367A CN101646436B (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproductive technology
EP06747719A EP1879572B1 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
MX2007014022A MX2007014022A (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction.
DE602006021736T DE602006021736D1 (en) 2005-05-10 2006-05-10 USE OF ANTAGONISTS OF OXYTOCIN AND / OR VASOPRESSIN IN ASSISTED REPRODUCTION
PT06747719T PT1879572E (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
PCT/PL2006/000029 WO2006121362A2 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
ES06747719T ES2366130T3 (en) 2005-05-10 2006-05-10 USE OF OXYCHOCINE AND / OR VASOPRESINE ANTAGONISTS IN ASSISTED REPRODUCTION.
AT06747719T ATE507830T1 (en) 2005-05-10 2006-05-10 USE OF ANTAGONISTS OF OXYTOCIN AND/OR VASOPRESSIN IN ASSISTED REPRODUCTION
JP2008511075A JP4762308B2 (en) 2005-05-10 2006-05-10 Use of oxytocin and / or vasopressin antagonists in assisted reproduction
DK06747719.0T DK1879572T3 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and / or vasopressin in artificial insemination
AU2006244693A AU2006244693B2 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
SI200631039T SI1879572T1 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
US11/914,049 US20080318847A1 (en) 2005-05-10 2006-05-10 Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
IL186595A IL186595A (en) 2005-05-10 2007-10-11 Use of barusiban for the preparation of medicaments for an improved uterine receptivity in assisted reproduction
NO20076328A NO340956B1 (en) 2005-05-10 2007-12-10 Use of antagonists for oxytocin and / or vasopressin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL374954A PL374954A1 (en) 2005-05-10 2005-05-10 Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction

Publications (1)

Publication Number Publication Date
PL374954A1 true PL374954A1 (en) 2006-11-13

Family

ID=35999478

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374954A PL374954A1 (en) 2005-05-10 2005-05-10 Application of antagonists of oxytocin or antagonists of oxitocin and vasopressin in the manufacture of medicines used in procedures of aided reproduction

Country Status (1)

Country Link
PL (1) PL374954A1 (en)

Similar Documents

Publication Publication Date Title
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
HK1097607A1 (en) Polarizing devices and methods of making the same
IL212396A (en) 6-oxo-1,6-dihydropyridazines and use thereof in the manufacture of medicaments
EP1812030A4 (en) Anti-angiogenic peptides and methods of use thereof
EP1786451A4 (en) Anti-angiogenic peptides and methods of use thereof
IL183101A (en) Use of tetrahydrocannabivarin in the manufacture of medicaments
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
IL177744A0 (en) Aptamers and pharmaceutical compositions containing the same
IL177125A0 (en) Vertical nanotube semiconducteur device structures and methods of forming the same
EP1968649A4 (en) Protein nanoparticles and the use of the same
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
EP1900207A4 (en) Creating standardized playlists and maintaining coherency
HK1091199A1 (en) Quinazoline derivatives and use thereof in the manufacture of medicaments
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
ZA200900204B (en) Substituted piperidines that increase P53 activity and the uses thereof
IL181524A (en) Heterocyclic compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments
EP1999817A4 (en) Nanocomposite electrodes and related devices
PT1928457E (en) Quinolines and their therapeutic use
IL198364A0 (en) Compositions comprising alphavirus or alphavirus replicon particles and methods of producing the same
EP1890677A4 (en) Pharmaceutical compositions and use thereof
GB0516069D0 (en) Pharmaceutical and use thereof
HK1141312A1 (en) Cdca1 peptide and pharmaceutical agent comprising the same cdca1
DE602005006062D1 (en) Platelet-shaped composite particles and cosmetics containing the same
BRPI0816236A2 (en) Cdh3 peptide and medicinal agent containing the same
TWI368509B (en) Antituberculous therapeutic drugs and kit containing the same

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)